Persistent or Recurrent Angina Following Percutaneous Coronary Revascularization

Curr Cardiol Rep. 2022 Dec;24(12):1837-1848. doi: 10.1007/s11886-022-01820-3. Epub 2022 Oct 26.

Abstract

Purpose of review: Persistent or recurrent angina after percutaneous coronary intervention (PCI) has substantial patient morbidity and economic impact. As knowledge of the pathophysiology of this condition has evolved, new tools for accurate diagnosis and treatment have become available. We provide a current, comprehensive review of mechanisms of post-PCI angina, diagnostic strategies, and therapeutic options.

Recent findings: The routine use of functional testing during PCI may enable more accurate revascularization. Coronary vasomotor disorders commonly cause angina after PCI in the absence of obstructive epicardial CAD. Invasive coronary vasoreactivity testing can enable phenotype-guided therapy of coronary vasomotor disorders with improvement in angina. Multiple nonpharmacologic modalities to treat refractory angina are under development. A comprehensive approach to the diagnosis of persistent or recurrent angina after PCI with noninvasive and invasive techniques is required. An individualized, phenotype-guided management using lifestyle, pharmacologic, and nonpharmacologic modalities is necessary to optimize outcomes.

Keywords: Angina pectoris; Microvascular dysfunction; Percutaneous coronary intervention; Refractory angina.

Publication types

  • Review

MeSH terms

  • Angina Pectoris / etiology
  • Angina Pectoris / therapy
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Treatment Outcome